La Chine et la France se trouvent respectivement à deux extrêmités du continent eurasiatique. Les deux peuples se respectent et s'admirent l'un l'autre pour leur culture. Les contacts et les...La Chine et la France se trouvent respectivement à deux extrêmités du continent eurasiatique. Les deux peuples se respectent et s'admirent l'un l'autre pour leur culture. Les contacts et les échanges culturels entre ces deux pays remontent au temps très ancien.展开更多
Despite advances in current anti-cancer therapies,challenges such as drug resistance,toxicity,and tumor heterogeneity persist.The limitations of traditional single-target drugs and simple combination therapies are bec...Despite advances in current anti-cancer therapies,challenges such as drug resistance,toxicity,and tumor heterogeneity persist.The limitations of traditional single-target drugs and simple combination therapies are becoming increasingly apparent1.To address these issues,a novel treatment strategy,the artificially intelligent synergistic engineered drug(AISED)paradigm,merits further exploration.This paradigm is based on the systematic engineered integration of multiple active ingredients into a unified single entity through artificial intelligence(AI).This strategy is aimed at developing new anti-cancer drug designs involving multiple ingredients,multiple molecular targets,and multiple biological effects,for multiple cancer types,thereby providing a novel theoretical paradigm for overcoming existing treatment bottlenecks.展开更多
文摘La Chine et la France se trouvent respectivement à deux extrêmités du continent eurasiatique. Les deux peuples se respectent et s'admirent l'un l'autre pour leur culture. Les contacts et les échanges culturels entre ces deux pays remontent au temps très ancien.
文摘Despite advances in current anti-cancer therapies,challenges such as drug resistance,toxicity,and tumor heterogeneity persist.The limitations of traditional single-target drugs and simple combination therapies are becoming increasingly apparent1.To address these issues,a novel treatment strategy,the artificially intelligent synergistic engineered drug(AISED)paradigm,merits further exploration.This paradigm is based on the systematic engineered integration of multiple active ingredients into a unified single entity through artificial intelligence(AI).This strategy is aimed at developing new anti-cancer drug designs involving multiple ingredients,multiple molecular targets,and multiple biological effects,for multiple cancer types,thereby providing a novel theoretical paradigm for overcoming existing treatment bottlenecks.
